[Therapy of syphilis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001153:Arsphenamine / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000276:immunology; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D005060:Europe; D006666:History of Medicine; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D008628:Mercury / Q000627:therapeutic use; D002267:Muramoylpentapeptide Carboxypeptidase / Q000378:metabolism; D009494:Neurosyphilis / Q000134:cerebrospinal fluid; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use*; D010458:Peptidyl Transferases / Q000378:metabolism; D013587:Syphilis / Q000188:drug therapy* / Q000266:history; D013588:Syphilis Serodiagnosis; D013997:Time Factors; D014210:Treponema pallidum / Q000187:drug effects / Q000201:enzymology
D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D010406:Penicillins; D001153:Arsphenamine; D007455:Iodine; D010458:Peptidyl Transferases; D002267:Muramoylpentapeptide Carboxypeptidase; D008628:Mercury; D001729:Bismuth
Therapie der Syphilis